Dr Gurdip Azad

1)Azad G, Siddique M, Taylor B, Green A, O'Doherty J, Gariani J, Blake G, Mansi J, Goh V, Cook G. Reply to: Relevance of measurement uncertainty for quantitative response assessment of breast cancer bone metastases with ₁₈F-fluoride.

J Nucl Med. 2019 Apr;60(4):569

2)Azad GK, Taylor BP, Green A, Sandri I, Swampillai A, Harries M, Kristeleit H, Mansi J, Goh V, Cook GJR. Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [¹⁸F] fluorodeoxyglucose and [¹⁸F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging. Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):821-830.

3)Azad G, Siddique M, Cousin F, Taylor B, Green A, O’Doherty J, Gariani J, Blake GM, Mansi J, Goh V, Cook J.R G. Does measurement of 18F-fluoride plasma clearance improve response assessment of breast cancer bone metastases compared with standardised uptake values in 18F-fluoride PET/CT? Journal of Nuclear Medicine. 2019 Journal of Nuclear Medicine, 60(3), 322-327

4)Azad G, Cousin F, Siddique M, Taylor B, Goh V, Cook GJ. Does measurement of first-order and heterogeneity parameters improve response assessment of bone metastases in breast cancer compared to SUV_max in 18F-fluoride and 18F-FDG PET? European Journal of Nuclear Medicine and Molecular Imaging. 2019 Aug;21(4):781-789.

5)Azad GK, Taylor B, Green A, Sandri I, Swampillai A, Harries M, Kristeleit H, Mansi J, Goh V, Cook GJR. Comparison of whole-body MRI, 18F-FDG and 18F-fluoride PET/CT in therapy response assessment of bone metastases from breast cancer. Radiology. 2016 Oct;281(1):193-202

6)Azad GK, Taylor B, Rubello D, Colletti PM, Goh V, Cook GJ. Molecular and Functional Imaging of Bone Metastases in Breast and Prostate Cancers: An Overview. Clinical Nuclear Medicine.2016; 41(1)

7)Azad GK, Cook GJ. Multi-technique imaging of bone metastases: spotlight on PET-CT. Clinical Radiology. 2016; 71(7): 620-631

8)Cook GJ, Azad GK, Goh V. Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment. Journal of Nuclear Medicine. 2016; 57:27S-33S.

9)Mahajan A, Azad GK, Cook GJ. PET Imaging of Skeletal Metastases and Its Role in Personalizing Further Management. PET Clinics. 2016; 11(3):305-318

10)Cook GJ, Azad G, Padhani AR. Bone imaging in prostate cancer: the evolving roles of nuclear medicine and radiology. Clinical Translational Imaging. 2016; 4(6):439-447

11)Bashir U, Azad G, Siddique MM, Dhillon S, Patel N, Bassett P, Landau D,4, Goh V, Cook GJ. The effects of segmentation algorithms on the measurement of 18F-FDG PET texture parameters in non-small cell lung cancer. European Journal of Nuclear Medicine and Molecular Imaging. 2017; 7(1):60

12)Cook, GJ, Azad GK, Taylor B, Lee E, Morrison M, Hughes S, Morris S, Rudman S, Chowdhury S, Goh V. Imaging αvβ3 integrin expression in skeletal metastases with 99mTc-maraciclatide Single-Photon Emission Computed Tomography: detection and therapy response assessment. European Journal of Nuclear Medicine and Molecular Imaging. 2017

13)Cook, GJR, Azad, GK, Owczarczyk, KM, Siddique, MM & Goh, VJ-L 2017, 'Challenges and Promises of PET Radiomics' International Journal of Radiation Oncology Biology Physics. 2017

14)Book chapter:

Wiley book entitled Plastic and Reconstructive Surgery, edited by Ross D. Farhadieh, Neil Bulstrode, Sabrina Cugno   

Radiotherapy and soft tissues

Alavi-Mandell award for her publication in the Journal of Nuclear Medicine: “Does measurement of ¹⁸F-fluoride metabolic flux improve response assessment of breast cancer bone metastases compared with standardised uptake values in ¹⁸F-fluoride PET/CT"